RT Journal Article
SR Electronic
T1 Real-time monitoring the transmission potential of COVID-19 in Singapore, February 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.21.20026435
DO 10.1101/2020.02.21.20026435
A1 Amna Tariq
A1 Yiseul Lee
A1 Kimberlyn Roosa
A1 Seth Blumberg
A1 Ping Yan
A1 Stefan Ma
A1 Gerardo Chowell
YR 2020
UL http://medrxiv.org/content/early/2020/03/03/2020.02.21.20026435.abstract
AB Background The ongoing COVID-19 epidemic that spread widely in China since December 2019 is now generating local transmission in multiple countries including Singapore as of February 27, 2020. This highlights the need to monitor in real time the transmission potential of COVID-19. In Singapore, four major COVID-19 case clusters have emerged thus far.Methods Here we estimate the effective reproduction number, Rt, of COVID-19 in Singapore from the publicly available daily case series of imported and autochthonous cases by date of symptoms onset, after adjusting the local cases for reporting delays. We also derive the reproduction number from the distribution of cluster sizes using a branching process analysis.Results The effective reproduction number peaked with a mean value ∼1.1 around February 2nd, 2020 and declined thereafter. As of February 27th, 2020, our most recent estimate of Rt is at 0.5 (95% CI: 0.2,0.7) while an estimate of the overall R based on cluster size distribution is at 0.7 (95% CI: 0.5, 0.9).Conclusion The trajectory of the reproduction number in Singapore underscore the significant effects of containment efforts in Singapore while at the same time suggest the need to sustain social distancing and active case finding efforts to stomp out all active chains of transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementG.C. is supported by NSF grants 1610429 and 1633381.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available.